Taylor Boyd

Insider Reports History

Location
Wayne, PA
Signature
/s/ Christopher Sullivan, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Taylor Boyd:

Company Role Class Num Shares Value Price $ Report Date Ownership
Avalo Therapeutics, Inc. Chief Business Officer Stock Option (Right to Buy) 95,000 26 Feb 2026 Direct

Insider Reports Filed by Taylor Boyd

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AVTX Avalo Therapeutics, Inc. 26 Feb 2026 1 $0 4 Chief Business Officer 02 Mar 2026, 16:22
AVTX Avalo Therapeutics, Inc. 01 Oct 2025 1 $0 4 Chief Business Officer 06 Oct 2025, 16:28
AVTX Avalo Therapeutics, Inc. 01 Oct 2025 0 $0 3 Chief Business Officer 06 Oct 2025, 16:22